Foreword |
|
xi | |
Preface |
|
xiii | |
Contributors |
|
xv | |
Acknowledgments |
|
xvii | |
|
1 Molecular Basis of Cardiac Development |
|
|
|
|
|
|
The Heart Fields and Heart Tube Formation |
|
|
1 | (3) |
|
|
4 | (2) |
|
|
6 | (1) |
|
Ventricular Septation and Myocardial Patterning |
|
|
7 | (1) |
|
Conduction System Development |
|
|
8 | (1) |
|
|
9 | (2) |
|
|
11 | (2) |
|
|
13 | (2) |
|
Epicardial and Coronary Vascular Development |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
17 | (1) |
|
|
17 | (6) |
|
2 Cardiac Metabolism in Health and Disease |
|
|
|
|
|
23 | (1) |
|
|
23 | (1) |
|
|
23 | (6) |
|
Energy Expenditure: Work of the Heart |
|
|
29 | (1) |
|
Pathological Alterations in Myocardial Energy Metabolism |
|
|
30 | (3) |
|
Metabolism of Heart Failure |
|
|
33 | (1) |
|
Mitochondrial Mechanisms in Heart Disease |
|
|
34 | (1) |
|
|
35 | (2) |
|
3 Cardiac Atrophy and Remodeling |
|
|
|
|
|
Overview of Atrophic Cardiac Remodeling |
|
|
37 | (1) |
|
Models of Atrophic Remodeling |
|
|
37 | (1) |
|
Cardiac Workload Determines Cardiac Size |
|
|
38 | (1) |
|
Morphological Features of the Atrophic Heart |
|
|
39 | (1) |
|
Extracellular Matrix Remodeling with Cardiac Atrophy |
|
|
40 | (1) |
|
Protein Homeostasis in the Healthy and Atrophic Heart |
|
|
41 | (1) |
|
Metabolic Unloading of the Myocardium |
|
|
42 | (1) |
|
Signaling Pathways Activated During Cardiac Atrophy |
|
|
42 | (1) |
|
Molecular Alterations in Atrophic Remodeling: The Fetal Gene Program |
|
|
43 | (1) |
|
Contractile Function in Cardiac Atrophy |
|
|
44 | (1) |
|
Regulation of Atrophic Remodeling by microRNAs |
|
|
45 | (1) |
|
Atrophic Remodeling due to Cardiac Pathology |
|
|
45 | (2) |
|
Atrophic Remodeling as a Potential Therapeutic |
|
|
47 | (1) |
|
|
47 | (1) |
|
|
48 | (3) |
|
4 The Pathophysiology of Cardiac Hypertrophy and Heart Failure |
|
|
|
|
|
|
|
|
|
|
|
51 | (1) |
|
Etiology of Heart Failure |
|
|
51 | (2) |
|
|
53 | (4) |
|
|
57 | (1) |
|
Molecular Mechanisms of Pathologic LVH |
|
|
58 | (12) |
|
|
70 | (9) |
|
5 Ischemic Heart Disease and its Consequences |
|
|
|
|
|
79 | (1) |
|
Pathophysiology of Ischemia--Reperfusion Injury |
|
|
79 | (6) |
|
Therapeutic Strategies to Combat Myocardial Ischemia--Reperfusion Injury |
|
|
85 | (10) |
|
|
95 | (2) |
|
Summary and Concluding Remarks |
|
|
97 | (1) |
|
|
97 | (4) |
|
6 Pathophysiology of Cardiomyopathies |
|
|
|
|
|
|
|
|
101 | (1) |
|
|
101 | (1) |
|
|
102 | (1) |
|
Idiopathic Dilated Cardiomyopathy |
|
|
103 | (2) |
|
Chagas Disease-Related Cardiomyopathy |
|
|
105 | (1) |
|
|
106 | (1) |
|
Peripartum Cardiomyopathy |
|
|
107 | (1) |
|
Hypertrophic Cardiomyopathy |
|
|
108 | (1) |
|
Restrictive Cardiomyopathy |
|
|
109 | (2) |
|
Anderson-Fabry's Cardiomyopathy |
|
|
111 | (1) |
|
|
112 | (1) |
|
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia |
|
|
113 | (1) |
|
Left Ventricular Non-Compaction Cardiomyopathy |
|
|
114 | (1) |
|
Role Of Genetic Testing and Future Directions |
|
|
115 | (1) |
|
|
116 | (5) |
|
7 Cellular and Molecular Pathobiology of the Cardiac Conduction System |
|
|
|
|
|
|
|
Overview of the Cardiac Conduction System |
|
|
121 | (1) |
|
|
122 | (3) |
|
The Atrioventricular Node |
|
|
125 | (2) |
|
Bundle of His and Bundle Branches |
|
|
127 | (1) |
|
|
127 | (1) |
|
Role of Autonomic Nervous System |
|
|
128 | (1) |
|
Human Conduction System Disease |
|
|
129 | (3) |
|
MicroRNAs and Cardiac Conduction |
|
|
132 | (1) |
|
|
132 | (3) |
|
8 Molecular Pathobiology of Myocarditis |
|
|
|
|
|
|
|
135 | (1) |
|
|
136 | (3) |
|
|
139 | (7) |
|
|
146 | (7) |
|
|
153 | (1) |
|
Consensus Statement on EMB from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology |
|
|
154 | (1) |
|
|
155 | (6) |
|
9 Calcific and Degenerative Heart Valve Disease |
|
|
|
|
|
|
161 | (1) |
|
Normal Valve Function, Biomechanics, and Structure |
|
|
161 | (3) |
|
Valve Development, Post-Developmental Adaptation, and Aging |
|
|
164 | (2) |
|
Calcific Aortic Valve Disease (CAVD) |
|
|
166 | (2) |
|
|
168 | (4) |
|
|
172 | (1) |
|
Degenerative Mitral Valve Disease (DMVD) |
|
|
172 | (3) |
|
|
175 | (1) |
|
Animal Models of Mitral Valve Disease |
|
|
175 | (1) |
|
Future Research Opportunities in Heart Valve Disease: Key Questions |
|
|
176 | (1) |
|
|
177 | (4) |
|
10 Vasculogenesis and Angiogenesis |
|
|
|
Joseph F. Arboleda-Velasquez |
|
|
|
|
181 | (1) |
|
|
181 | (2) |
|
Developmental Abnormalities |
|
|
183 | (3) |
|
Angiogenic Component of Pathologies |
|
|
186 | (5) |
|
|
191 | (6) |
|
11 Diseases of Medium-Sized and Small Vessels |
|
|
|
|
|
|
197 | (1) |
|
Normal Vessel Wall Structure |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
199 | (3) |
|
|
202 | (1) |
|
|
203 | (2) |
|
|
205 | (7) |
|
|
212 | (1) |
|
|
213 | (1) |
|
Vascular Trauma and the Hypothenar Hammer Syndrome |
|
|
214 | (1) |
|
Vasospasm and Raynaud's Phenomenon |
|
|
215 | (2) |
|
|
217 | (4) |
|
12 Pathophysiology of Atherosclerosis |
|
|
|
|
|
|
|
221 | (1) |
|
|
222 | (1) |
|
Lipids in Atherosclerosis |
|
|
222 | (1) |
|
|
223 | (1) |
|
Inflammation in Atherosclerosis |
|
|
224 | (1) |
|
The Atherosclerotic Plaque |
|
|
225 | (3) |
|
Aortic Atherosclerosis and Atherosclerotic Aneurysms |
|
|
228 | (1) |
|
The Genetics of Atherosclerosis |
|
|
229 | (3) |
|
|
232 | (2) |
|
Laboratory and Animal Models |
|
|
234 | (1) |
|
|
235 | (1) |
|
|
235 | (4) |
|
13 Genetic Diseases of the Aorta (Including Aneurysms) |
|
|
|
|
The Normal Aorta: Histology and Function |
|
|
239 | (1) |
|
Gross Pathologic Changes to the Aorta |
|
|
240 | (1) |
|
Demographics of Aneurysms and Dissections |
|
|
241 | (1) |
|
Histopathologic Changes to the Aorta |
|
|
242 | (2) |
|
Specific Genetic Syndromes and Causes of Aneurysm |
|
|
244 | (5) |
|
Non-Genetic Causes of Aortic Aneurysm |
|
|
249 | (1) |
|
Evidence for the TGF-β Pathway to be a Unifying Mechanism of Aortic Aneurysm |
|
|
250 | (1) |
|
TGF-β Canonical and Non-Canonical Signaling in the Ascending Aorta |
|
|
250 | (1) |
|
TGF-β Signaling in Ascending Aortic Diseases |
|
|
251 | (1) |
|
TGF-β Signaling in the Descending Aorta |
|
|
252 | (1) |
|
|
252 | (1) |
|
|
253 | (1) |
|
|
253 | (1) |
|
|
253 | (4) |
|
14 Blood Pressure Regulation and Pathology |
|
|
|
|
|
257 | (1) |
|
Definition of Essential (Primary) Hypertension |
|
|
257 | (2) |
|
|
259 | (2) |
|
Physiological Control of Blood Pressure |
|
|
261 | (1) |
|
Cardiac Output and Hypertension |
|
|
261 | (1) |
|
The Sympathetic Nervous System and Hypertension |
|
|
261 | (1) |
|
The Kidney and Hypertension |
|
|
261 | (1) |
|
|
262 | (1) |
|
The Renin--Angiotensin System (RAS) |
|
|
262 | (2) |
|
Angiotensin Receptors and Signaling |
|
|
264 | (1) |
|
The Vascular System and Hypertension |
|
|
265 | (4) |
|
Reactive Oxygen Species, Oxidative Stress, and Human Hypertension |
|
|
269 | (1) |
|
New Drugs, Procedures, and Devices in the Management of Hypertension |
|
|
270 | (1) |
|
|
271 | (1) |
|
|
271 | (1) |
|
|
271 | (6) |
|
15 Venous and Arterial Thrombosis |
|
|
|
|
|
|
277 | (1) |
|
|
277 | (9) |
|
|
286 | (6) |
|
|
292 | (5) |
|
16 The Pericardium and its Diseases |
|
|
|
|
|
|
The Pericardium and its Diseases |
|
|
297 | (2) |
|
|
299 | (1) |
|
|
299 | (1) |
|
Pericardiocentesis and Biopsy |
|
|
299 | (1) |
|
Specific Forms of Pericarditis |
|
|
299 | (12) |
|
|
311 | (4) |
Index |
|
315 | |